Jun 27th, 2019
BridgeBio Pharma Soars in Nasdaq Trading Debut
BridgeBio Pharma CEO Neil Kumar discusses the company's trading debut after raising $348.5 million in its initial public offering. He speaks with Bloomberg's Ed Hammond on "Bloomberg Markets: The Close." (Corrects headline and company name in description.) (Source: Bloomberg_TV)











